Cardiac ion channels regulation in PM-challenged CREBA133
mice. (A) Genome-wide expression profiling of
PM-exposed left ventricular tissues from CREBA133 mice
identified a large set of dysregulated genes with 1,927 probe sets
(Table E3) when compared with PBS-challenged CD1 mice (Significance
Analysis of Microarrays software). Comparison between PM- and
PBS-exposed CREBA133 mice shows that 60 of the 1,927 probe
sets display differential expression (Student's t test
P value ≤ 0.05). The heat map (dChip software) of
these 60 genes across the four groups is displayed.
Red, white, or blue
color represents expression level above, at, or below the mean level,
respectively. (B) The expression pattern of
dysregulated genes involved in ion transport (Gene Ontology ID: 0006811
and 0043269) is displayed across all left ventricle tissue samples.
Noted is the up-regulation of Na+ channels and the
Na+–Ca2+ exchanger with concominant
down-regulation of K+ channels, events which potentially
alter myocardial Na+ and Ca2+ homeostasis,
resulting in increased [Ca2+]i and
[Na+]i, tissue hyperexcitability, and
arrhythmogenesis. Up-regulated nonchannel proteins, such as ankyrin and
gelsolin, also participate in localization and regulation of pore
function, including L-type Ca2+ channel activity in
PM-challenged CREBA133 mice. (C) Expression
and posttranslational modification of the voltage-gated, type V cardiac
muscle α-subunit Na+ channel encoded by
SCN5a. This Na+ channel protein was
analyzed by Western blot in CD1 and CREBA133 left ventricle
tissues. The late Na+ channel protein is up-regulated in
CREBA133 ventricle tissues but is not altered
significantly by PM exposure. (D and
E) The cardiac Na+ channel subunit encoded
by SCN5A was immunoprecipitated (IP) in left ventricle protein lysates
and subjected to Western blotting (IB) for phosphotyrosine (PT) or
nitrotyrosine (NT). Increased phosphorylation and nitration of late
Na+ channel protein tyrosine residues was observed in CD1
and CREBA133 mice after PM exposure (representative blots
from more than three independent experiments). Bar
graphs were generated from quantification of Western blots
from four independent experiments. *P < 0.05
compared with CD-1 control. **P < 0.05 compared with
CREBA133 control. (F) QT interval
alterations evoked by PM or by ranolazine treatment. QT intervals were
quantified from ECG recordings in CREBA133 mice. PM exposure
significantly prolonged QT intervals in CREBA133, mice with
ranolazine pretreatment significantly reversing PM-mediated QT interval
elongation. n = 4. *P < 0.05
compared with PM-alone group. (G) Inhibition of late
sodium channel by ranolazine pretreatment (Rano, 50 mg/kg,
intraperitoneally) attenuates PM-induced ventricular arrhythmias
reflected by significantly reduced VAS in PM-treated CREBA133
mice.